EP Patent

EP0364235A1 — Physiologically active peptide composition for nasal administration

Assigned to Asahi Kasei Corp · Expires 1990-04-18 · 36y expired

What this patent protects

A powder composition suitable for nasal administration comprising a physiologically active peptide as an active ingredient and a lactone of a water-soluble organic acid as an absorption promoter.

USPTO Abstract

A powder composition suitable for nasal administration comprising a physiologically active peptide as an active ingredient and a lactone of a water-soluble organic acid as an absorption promoter.

Drugs covered by this patent

Patent Metadata

Patent number
EP0364235A1
Jurisdiction
EP
Classification
—
Expires
1990-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Asahi Kasei Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.